Barriers to Protocol Adherence in Emergency Departments and Evidence-Based Strategies for Successful Implementation: A Scoping Review
Abstract
Background: Emergency departments (EDs) operate under severe time pressure, diagnostic uncertainty, and resource constraints, making the consistent application of clinical protocols challenging. This scoping review aimed to map the barriers to protocol adherence and the strategies reported to support implementation in emergency care. Methods: PubMed/MEDLINE, Scopus, and Web of Science were searched for publications from January 2000 to June 2026. Following predefined eligibility criteria, 58 publications were included and charted according to clinician-related, guideline-related, patient-related, and organizational determinants, and we reported the implementation strategies. No formal design-specific risk-of-bias or certainty-of-evidence assessment was performed; therefore, the synthesis was intended to map the available evidence rather than establish the comparative effectiveness. Results: Commonly reported barriers included limited guideline knowledge and clinical experience, cognitive overload and occupational fatigue, poor guideline usability and workflow compatibility, patient communication difficulties and clinical complexity, overcrowding, staffing shortages, and limited organizational support. The reported strategies included education and simulation, audit and feedback, clinical decision support, workflow redesign, multidisciplinary collaboration, and leadership engagement. However, the heterogeneity in study designs, clinical settings, definitions of adherence, and…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.